Posts by Sandra Ansanay-Alex
Givaudan expands its Protein Hub in Zurich to create dairy alternatives
Geneva-based Givaudan has expanded the Protein Hub at its flagship Zurich Innovation Centre in Kemptthal, to support the growth of dairy alternatives. The expanded Hub offers specialised expertise, state-of-the-art digital technologies, and an integrated portfolio of solutions designed specifically for dairy alternatives to accelerate new product development and co-create exciting new food experiences in collaboration…
Read MoreSulfiscon and biped.ai recipients of the Biopôle Start-up Fund
The fund offers up to CHF 90,000 a year, over three consecutive years, to promising life sciences ventures. Sulfiscon develops small molecule allosteric modulators that can be administered as drugs to treat pathological calcification disorders. Pathological calcification can affect different organs and is associated with ageing and diseases. At present, surgery is the…
Read MorePeriVision raises between CHF 0.5 and 1 Million in a Seed Round
PeriVision is utilizing the power of artificial intelligence (AI), virtual reality (VR), and cloud computing to redefine eye testing and care. Perivision, a University of Bern spin-off now located at Biopôle, is developing a portfolio of virtual eye tests conducted on commercial VR headsets. Doctors can easily configure and analyze the test results on…
Read MoreA patient in remission from HIV after a bone marrow transplant
The HUG and the Institut Pasteur have announced an exceptional case of HIV remission. A promising discovery. The patient has been living with HIV since the early 1990s and has always been on antiretroviral treatment. In 2018, to treat a particularly aggressive form of leukaemia, he underwent a stem cell transplant. One month after…
Read MoreCERN Venture Connect
The CERN Venture Connect (CVC) programme aims to act as a connector to bring together great entrepreneurs, provide them with cutting edge technologies and connect them to investors and incubators who can help them succeed. Why apply to CVC? Curated state-of-art technologies Network of venture capitalists, incubators, mentors and service provider A bridge…
Read MoreBiped wins the Prix de la canne blanche
The Swiss Central Union for the Blind (UCBA) awards projects for blind, partially sighted and deaf-blind people. Twenty-one projects were submitted for the ninth edition of the competition, and the Vaud based Biped.ai won the contest. Biped – an intelligent co-pilot for blind people (picture) Biped is a co-pilot for blind people, worn like…
Read MoreThe Swiss Health Valley Region on One TV
Magali Bischof, BioAlps’ Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch the video from 18’00. ▶️ Video link
Read Moreten23 health announces expansion with the launch of quality control services
ten23 health® announces the launch of “quality control” service offerings in Switzerland for release and stability testing of clinical and commercial sterile drug products according to international cGMP standards. The new quality control division will be set up in Basel and Visp. In Basel ten23 health® will offer physico-chemical testing, including content, purity, identity…
Read MoreComphya SA launches clinical study for erectile dysfunction in Brazil
After raising CHF 850 000 in January, and starting a clinical trial in Australia, the Swiss Medtech startup launches a clinical trial in Brazil for its neuromodulator to treat erectile dysfunction in spinal cord injured patients. Comphya SA is a pioneering medical technology company, based in canton of Vaud, Switzerland. The clinical study was…
Read MoreInnovation at Hôpital de la Tour
On Thursday 1 June, the Swiss Health Valley Community was received by Hôpital de la Tour in Meyrin during a BioAlps 4à6 event. The 70 participants discovered the “Value Based Health Care” strategy implemented by the hospital and the ambitious project of health campus. They also had the opportunity to visit the radio-oncology and the…
Read More